# IMMUNOLOGY QUALITY ASSESSMENT PROGRAM

> **NIH NIH N01** · DUKE UNIVERSITY · 2020 · $1,507,523

## Abstract

The purpose of the Immunology Quality Assessment Program (IQA) is to continue and provide a resource to (1) evaluate the abilities of U.S. and non-U.S. laboratories to accurately and reliably perform study-specified immunological tests (with focus on CD4 and CD8 T cell lymphocyte counts and percentages) and viable PBMC freezing, (2) advise and train when deficiencies are identified, (3) evaluate immunology-based novel technologies (with focus on novel, simple tests for diagnosis and disease monitoring) for implementation in multi-site NIAID trials, and (4) maintain a computerized data management system and document library that include lab performance data and guidance documents. IQA will continue to support laboratories that are part of current and future NIAID-sponsored clinical trial networks

## Key facts

- **NIH application ID:** 10189437
- **Project number:** 272201400014C-P00008-9999-1
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** Thomas Denny
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,507,523
- **Award type:** —
- **Project period:** 2014-09-30 → 2021-09-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10189437

## Citation

> US National Institutes of Health, RePORTER application 10189437, IMMUNOLOGY QUALITY ASSESSMENT PROGRAM (272201400014C-P00008-9999-1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10189437. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*